Microneedle-Based Intradermal Versus Subcutaneous Administration of Regular Human Insulin or Insulin Lispro: Pharmacokinetics and Postprandial Glycemic Excursions in Patients with Type 1 Diabetes

Diabetes Technology and Therapeutics - Tập 13 Số 4 - Trang 443-450 - 2011
Ronald J. Pettis1, Laurence Hirsch2, Christoph Kapitza3, Leszek Nosek3, Ulrike Hövelmann3, Heinz-Joerg Kurth3, Diane Sutter1, Noel G. Harvey1, Lutz Heinemann3
1BD Technologies, Research Triangle Park, North Carolina.
2BD Medical–Diabetes Care, Franklin Lakes, New Jersey.
3Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.2165/00044011-200828040-00001

10.1001/archinte.163.11.1306

10.1210/edrv.19.5.0343

Abbatecola AM, 2005, J Endocrinol Invest, 28, 105

Gin H, 2000, Diabetes Metab, 26, 265

10.2337/diacare.26.3.881

10.2337/dc09-S333

10.2337/dc09-S334

10.2337/db09-9028

10.1007/s00125-006-0203-x

10.1177/193229680900300631

10.1001/archinte.165.12.1337

10.2337/diacare.24.10.1734

Pettis RJ, 2004, Drug Delivery Companies Report, Spring/Summer

10.1007/s11095-010-0123-9

10.1089/dia.2010.0184

1997, AAMI Standards and Recommended Practices,Vol. 4: Biological Evaluation of Medical Devices: ISO 10993-10:2010, Biological Evaluation of Medical Devices—Part 10: Tests for Irritation and Skin Sensitization

10.1089/dia.2008.0103

10.1185/03007995.2010.481203